Condition: Endometrial Cancer · Sponsor: Haukeland University Hospital
MoMaTEC2 aims to test, in clinically oriented studies, the applicability of already identified and promising molecular biomarkers, to promote individualisation of treatment for patients with endometrial cancer. Predominantly, but not exclusively, such biomarkers have shown to be interesting in retrospective analysis of our large prospectively collected MoMaTEC1 series. Part 1: Performance of a phase 4 implementation trial for optimised stratification of surgical treatment, specifically the performance of (para-aortic and pelvic) lymphadenectomy guided by validated biomarkers. Part 2: Performance of a phase 2b clinical biomarker study to evaluate the predictive potential of the biomarker stathmin for taxane treatment response in endometrial and ovarian cancer. In this study stathmin will be used as integrated biomarker.
This description comes directly from the study's public registry record.
Jone Trovik, MD PhD Prof · +4755974200 · jone.trovik@k2.uib.no
Henrica MJ Werner, MD PhD MRCOG · +4755974200 · henrica.werner@k2.uib.no
Always discuss trial participation with your own doctor first.
| Radboud university hospital | Nijmegen, Netherlands | Not Yet Recruiting |
| Women's hospital, Haukeland university hospital | Bergen, Hordaland, Norway | Recruiting |
| Ålesund hospital | Ålesund, Norway | Recruiting |
| Førde central hospital | Førde, Norway | Recruiting |
| Sørlandet hospital | Kristiansand, Norway | Not Yet Recruiting |
| Akershus University hospital | Oslo, Norway | Recruiting |
| Stavanger university hospital | Stavanger, Norway | Recruiting |
| St Olav university hospital | Trondheim, Norway | Recruiting |
| Spsk No 1 | Lublin, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02543710